Reducing Health Disparities Press Releases
On September 13, more than 600 cancer patients, survivors, and their loved ones from all 50 states and almost every congressional district united in Washington, D.C.
Congressman Larry Bucshon, M.D. received the National Distinguished Advocacy Award this week, the most prestigious award presented by the American Cancer Society Cancer Action Network (ACS CAN), in recognition of his significant contributions to the fight against cancer.
Advocates Were Among the First to Meet In-Person with Members Since the Pandemic’s Start; Will Ask For Increased Cancer Research Funding
Advocates Were Among the First to Meet In-Person with Members Since the Pandemic’s Start; Will Ask For Increased Cancer Research Funding
Advocates Were Among the First to Meet In-Person with Members Since the Pandemic’s Start; Will Ask For Increased Cancer Research Funding
ATLANTA, GA – September 13, 2022 – United States Senator Raphael Warnock received the National Distinguished Advocacy Award today, the most prestigious award presented by the American Cancer Society Cancer
The California Assembly Health Committee passed a bill today that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence.
El Condado de San Diego votó a favor de un presupuesto que respalda la ordenanza de licencias de minoristas de tabaco. Este presupuesto permite una aplicación de la ordenanza que incluye monitoreo anual, multas, suspensión y revocación de licencias para minoristas que no cumplen con la ordenanza.
Discrimination in health care and quality of care remain barriers to receiving care for Black and Hispanic cancer patients and survivors, according to preliminary data from a forthcoming American Cancer Society Cancer Action Network (ACS CAN) Survivor Views survey.
Eighty-seven organizations representing patients with chronic and acute health conditions, sent a letter to Congress today urging them to improve the diversity of enrollment in clinical trials as part of this year’s Prescription Drug User Fee Act (PDUFA) reauthorization.